- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 15:58 | China clears its first drug for chronic hepatitis D | ||
| 13:58 | Boehringer signs €1bn+ deal for Simcere IBD candidate | ||
| 13:58 | Roche claims midstage win for obesity injectable | ||
| 12:58 | Vaccination fall costs UK its measles elimination status | ||
| 11:58 | Introducing the Sunday Times Tech 100: Life sciences part 2 | ||
| Mo | Bausch Health hit as Xifaxan successor flunks trials | ||
| Mo | MSD said to have pulled back from Revolution Medicines deal | ||
| Mo | COPD patients will get access to Dupixent via NHS | ||
| Mo | Introducing the Sunday Times Tech 100: Life sciences part 1 | ||
| Fr | Digital osteoarthritis, bulimia tools backed for NHS use | ||
| Fr | Sanofi plans amlitelimab dermatitis filing after new readout | ||
| Fr | Corxel's raises $287m for obesity drug, and other financings | ||
| Fr | Change of heart as NICE backs prostate cancer drug Talzenna | ||
| Fr | Ovarian cancer data restores faith in Corcept's relacorilant | ||
| Do | J&J says 2026 sales could top $100 billion | ||
| Do | Amazon joins the AI health assistant movement | ||
| Do | NICE backs Roche lupus drug that supports kidney function | ||
| Do | US checks out of WHO, leaving its bill unsettled | ||
| Do | 11 high-impact drugs to look out for in 2026 | ||
| Mi | EU approves Otsuka's long-acting HAE drug Dawnzera | ||
| Mi | Hopstem maps course to bring stem cell stroke therapy to US | ||
| Mi | ImmunityBio rises as route opens to broader Anktiva label | ||
| Mi | Call goes out for type 1 diabetes screening in UK | ||
| Mi | Data builds behind Moderna's skin cancer vaccine | ||
| 20.01. | J&J bets on Isomorphic for AI-powered drug hunt |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.